Cite
HARVARD Citation
Moore, K. et al. (n.d.). An open‐label study to estimate the effect of steady‐state erythromycin on the pharmacokinetics, pharmacodynamics, and safety of a single dose of rivaroxaban in subjects with renal impairment and normal renal function. Journal of clinical pharmacology. pp. 1407-1420. [Online].